Exosome-Displayed Fusion Proteins Unlock TNF Receptor Superfamily Agonism for Cancer Immunotherapy

Time: 3:30 pm
day: Conference Day Two

Details:

• Overcoming the challenge of TNFRSF agonism: limitations of traditional protein biologics
• Engineering multivalent exosome display using a novel type II transmembrane anchor
• Demonstrating superior agonist activity: In vitro and in vivo validation

NEW COMPANY!

Speakers:

Mickey Pentecost Mickey Pentecost is the CSO, Founder & Board Director at Diadem Biotherapeutics. Dr. Pentecost is a bioengineer with expertise in cell and molecular biology, data Read more